All Type of News


Expanded inspection of imported oriental medicines by private organization eyed

The Korea Food and Drug Administration (KFDA) has announced the revised Management Regulation of Imported Drug on March 7th, to this effect that imported oriental medicines, such as deer antler, ox bezoar and agalloch...

New price proposal of Gleevec on sharp backlash

The Joint Counter Measure Council for Gleevec Pricing and Expansion of Drug Public Benefits (hereinafter called Gleevec Pricing Council: GPC), a civic organization for fighting against Norvatis' Gleevec pricing policy...

Mounting criticism on lukewarm reactions by KPA over the reduced treatment charges

Business sources say that the Korea Pharmaceutical Association has been strongly criticized for its lukewarm countermeasures over the reduced treatment charges. Outwardly, the KPA made a strong opposition to the re...

Trast ranks highest in brand image

Trast of SK Pharm placed in the first place having the most influential brand image among anti-arthritic drugs, according to a recent survey of Korea Management Association. SK Pharm says that a patch type of Trast...

21% minority of pharmacies to predominate prescription filling.

The MOHW plans to take a strong preventive measure against the prescription business collusion between medical institutions and pharmacies based on the scrutinized data conducted by the HIRA (Health Insurance Reviesw ...

License procedures of oriental medicines to be further ameliorated

The Korea Food and Administration says it will establish shortly a working committee to formulate the specific license regulations and criteria for screening the safety and efficacy of oriental medicines so as to faci...

Drug industry strongly to resist against 5% drug price slash.

To save about 200 billion won of the NHI budget the MOHW is attempting to slash overall drug prices by 5% on average, which provokes rage to the drug industry. The MOHW proposed to the drug industry for 5% price re...

Novartis proposes 24,050 won for Glivec's insurance price per tablet

Novartis Korea says that it has recently proposed to the Ministry of Health and Welfare (MOHW) the insurance price of Glivec by 24,050 won per tablet based on the local drug pricing assessment system of new drugs. ...

Zuellig's unfair contract to raise problems.

The distribution agreements made with Zuellig found unfair clauses, raising a lot of problems in the drug wholesale circles including the lawsuit against Zuellig filed by Dongwon Wholesale Co. for compensation of thei...

Stamina health foods market using silkworm and herbs getting heated

Business industry sources say that the domestic stamina health foods market, which will mark a turnover of about 10 billion won this year, has emerged as an arena of tripartite competition among the domestic firms: ...

Most Read News


April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
SunMonTueWedThuFriSat
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.